Response of rheumatoid arthritis-associated pyoderma gangrenous to the JAK1 inhibitor upadacitinib

J Dtsch Dermatol Ges. 2022 Apr;20(4):522-524. doi: 10.1111/ddg.14716. Epub 2022 Mar 10.
No abstract available

Publication types

  • Letter